Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Therapy for Breast Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Brand Drugs
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Targeted Therapy for Breast Cancer Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Therapy for Breast Cancer Market Perspective (2018-2029)
2.2 Targeted Therapy for Breast Cancer Growth Trends by Region
2.2.1 Global Targeted Therapy for Breast Cancer Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Targeted Therapy for Breast Cancer Historic Market Size by Region (2018-2024)
2.2.3 Targeted Therapy for Breast Cancer Forecasted Market Size by Region (2024-2029)
2.3 Targeted Therapy for Breast Cancer Market Dynamics
2.3.1 Targeted Therapy for Breast Cancer Industry Trends
2.3.2 Targeted Therapy for Breast Cancer Market Drivers
2.3.3 Targeted Therapy for Breast Cancer Market Challenges
2.3.4 Targeted Therapy for Breast Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Therapy for Breast Cancer Players by Revenue
3.1.1 Global Top Targeted Therapy for Breast Cancer Players by Revenue (2018-2024)
3.1.2 Global Targeted Therapy for Breast Cancer Revenue Market Share by Players (2018-2024)
3.2 Global Targeted Therapy for Breast Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Targeted Therapy for Breast Cancer Revenue
3.4 Global Targeted Therapy for Breast Cancer Market Concentration Ratio
3.4.1 Global Targeted Therapy for Breast Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Therapy for Breast Cancer Revenue in 2022
3.5 Targeted Therapy for Breast Cancer Key Players Head office and Area Served
3.6 Key Players Targeted Therapy for Breast Cancer Product Solution and Service
3.7 Date of Enter into Targeted Therapy for Breast Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Therapy for Breast Cancer Breakdown Data by Type
4.1 Global Targeted Therapy for Breast Cancer Historic Market Size by Type (2018-2024)
4.2 Global Targeted Therapy for Breast Cancer Forecasted Market Size by Type (2024-2029)
5 Targeted Therapy for Breast Cancer Breakdown Data by Application
5.1 Global Targeted Therapy for Breast Cancer Historic Market Size by Application (2018-2024)
5.2 Global Targeted Therapy for Breast Cancer Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Targeted Therapy for Breast Cancer Market Size (2018-2029)
6.2 North America Targeted Therapy for Breast Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Targeted Therapy for Breast Cancer Market Size by Country (2018-2024)
6.4 North America Targeted Therapy for Breast Cancer Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Therapy for Breast Cancer Market Size (2018-2029)
7.2 Europe Targeted Therapy for Breast Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Targeted Therapy for Breast Cancer Market Size by Country (2018-2024)
7.4 Europe Targeted Therapy for Breast Cancer Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Therapy for Breast Cancer Market Size (2018-2029)
8.2 Asia-Pacific Targeted Therapy for Breast Cancer Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Targeted Therapy for Breast Cancer Market Size by Region (2018-2024)
8.4 Asia-Pacific Targeted Therapy for Breast Cancer Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Therapy for Breast Cancer Market Size (2018-2029)
9.2 Latin America Targeted Therapy for Breast Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Targeted Therapy for Breast Cancer Market Size by Country (2018-2024)
9.4 Latin America Targeted Therapy for Breast Cancer Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Therapy for Breast Cancer Market Size (2018-2029)
10.2 Middle East & Africa Targeted Therapy for Breast Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Targeted Therapy for Breast Cancer Market Size by Country (2018-2024)
10.4 Middle East & Africa Targeted Therapy for Breast Cancer Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Detail
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Targeted Therapy for Breast Cancer Introduction
11.1.4 Eli Lilly and Company Revenue in Targeted Therapy for Breast Cancer Business (2018-2024)
11.1.5 Eli Lilly and Company Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Targeted Therapy for Breast Cancer Introduction
11.2.4 Roche Revenue in Targeted Therapy for Breast Cancer Business (2018-2024)
11.2.5 Roche Recent Development
11.3 Merck & Co.
11.3.1 Merck & Co. Company Detail
11.3.2 Merck & Co. Business Overview
11.3.3 Merck & Co. Targeted Therapy for Breast Cancer Introduction
11.3.4 Merck & Co. Revenue in Targeted Therapy for Breast Cancer Business (2018-2024)
11.3.5 Merck & Co. Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Targeted Therapy for Breast Cancer Introduction
11.4.4 Novartis Revenue in Targeted Therapy for Breast Cancer Business (2018-2024)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Targeted Therapy for Breast Cancer Introduction
11.5.4 Pfizer Revenue in Targeted Therapy for Breast Cancer Business (2018-2024)
11.5.5 Pfizer Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Detail
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA Targeted Therapy for Breast Cancer Introduction
11.6.4 Merck KGaA Revenue in Targeted Therapy for Breast Cancer Business (2018-2024)
11.6.5 Merck KGaA Recent Development
11.7 Astellas
11.7.1 Astellas Company Detail
11.7.2 Astellas Business Overview
11.7.3 Astellas Targeted Therapy for Breast Cancer Introduction
11.7.4 Astellas Revenue in Targeted Therapy for Breast Cancer Business (2018-2024)
11.7.5 Astellas Recent Development
11.8 Janssen Biotech
11.8.1 Janssen Biotech Company Detail
11.8.2 Janssen Biotech Business Overview
11.8.3 Janssen Biotech Targeted Therapy for Breast Cancer Introduction
11.8.4 Janssen Biotech Revenue in Targeted Therapy for Breast Cancer Business (2018-2024)
11.8.5 Janssen Biotech Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Detail
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Targeted Therapy for Breast Cancer Introduction
11.9.4 Bristol-Myers Squibb Revenue in Targeted Therapy for Breast Cancer Business (2018-2024)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Gilead Sciences
11.10.1 Gilead Sciences Company Detail
11.10.2 Gilead Sciences Business Overview
11.10.3 Gilead Sciences Targeted Therapy for Breast Cancer Introduction
11.10.4 Gilead Sciences Revenue in Targeted Therapy for Breast Cancer Business (2018-2024)
11.10.5 Gilead Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Targeted Therapy for Breast Cancer Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Brand Drugs
Table 3. Key Players of Generic Drug
Table 4. Global Targeted Therapy for Breast Cancer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Targeted Therapy for Breast Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Targeted Therapy for Breast Cancer Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Targeted Therapy for Breast Cancer Market Share by Region (2018-2024)
Table 8. Global Targeted Therapy for Breast Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Targeted Therapy for Breast Cancer Market Share by Region (2024-2029)
Table 10. Targeted Therapy for Breast Cancer Market Trends
Table 11. Targeted Therapy for Breast Cancer Market Drivers
Table 12. Targeted Therapy for Breast Cancer Market Challenges
Table 13. Targeted Therapy for Breast Cancer Market Restraints
Table 14. Global Targeted Therapy for Breast Cancer Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Targeted Therapy for Breast Cancer Market Share by Players (2018-2024)
Table 16. Global Top Targeted Therapy for Breast Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Therapy for Breast Cancer as of 2022)
Table 17. Ranking of Global Top Targeted Therapy for Breast Cancer Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Targeted Therapy for Breast Cancer Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Targeted Therapy for Breast Cancer Product Solution and Service
Table 21. Date of Enter into Targeted Therapy for Breast Cancer Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Targeted Therapy for Breast Cancer Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Targeted Therapy for Breast Cancer Revenue Market Share by Type (2018-2024)
Table 25. Global Targeted Therapy for Breast Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Targeted Therapy for Breast Cancer Revenue Market Share by Type (2024-2029)
Table 27. Global Targeted Therapy for Breast Cancer Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Targeted Therapy for Breast Cancer Revenue Market Share by Application (2018-2024)
Table 29. Global Targeted Therapy for Breast Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Targeted Therapy for Breast Cancer Revenue Market Share by Application (2024-2029)
Table 31. North America Targeted Therapy for Breast Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Targeted Therapy for Breast Cancer Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Targeted Therapy for Breast Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Targeted Therapy for Breast Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Targeted Therapy for Breast Cancer Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Targeted Therapy for Breast Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Targeted Therapy for Breast Cancer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Targeted Therapy for Breast Cancer Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Targeted Therapy for Breast Cancer Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Targeted Therapy for Breast Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Targeted Therapy for Breast Cancer Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Targeted Therapy for Breast Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Targeted Therapy for Breast Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Targeted Therapy for Breast Cancer Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Targeted Therapy for Breast Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 46. Eli Lilly and Company Company Detail
Table 47. Eli Lilly and Company Business Overview
Table 48. Eli Lilly and Company Targeted Therapy for Breast Cancer Product
Table 49. Eli Lilly and Company Revenue in Targeted Therapy for Breast Cancer Business (2018-2024) & (US$ Million)
Table 50. Eli Lilly and Company Recent Development
Table 51. Roche Company Detail
Table 52. Roche Business Overview
Table 53. Roche Targeted Therapy for Breast Cancer Product
Table 54. Roche Revenue in Targeted Therapy for Breast Cancer Business (2018-2024) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Merck & Co. Company Detail
Table 57. Merck & Co. Business Overview
Table 58. Merck & Co. Targeted Therapy for Breast Cancer Product
Table 59. Merck & Co. Revenue in Targeted Therapy for Breast Cancer Business (2018-2024) & (US$ Million)
Table 60. Merck & Co. Recent Development
Table 61. Novartis Company Detail
Table 62. Novartis Business Overview
Table 63. Novartis Targeted Therapy for Breast Cancer Product
Table 64. Novartis Revenue in Targeted Therapy for Breast Cancer Business (2018-2024) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Pfizer Company Detail
Table 67. Pfizer Business Overview
Table 68. Pfizer Targeted Therapy for Breast Cancer Product
Table 69. Pfizer Revenue in Targeted Therapy for Breast Cancer Business (2018-2024) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Merck KGaA Company Detail
Table 72. Merck KGaA Business Overview
Table 73. Merck KGaA Targeted Therapy for Breast Cancer Product
Table 74. Merck KGaA Revenue in Targeted Therapy for Breast Cancer Business (2018-2024) & (US$ Million)
Table 75. Merck KGaA Recent Development
Table 76. Astellas Company Detail
Table 77. Astellas Business Overview
Table 78. Astellas Targeted Therapy for Breast Cancer Product
Table 79. Astellas Revenue in Targeted Therapy for Breast Cancer Business (2018-2024) & (US$ Million)
Table 80. Astellas Recent Development
Table 81. Janssen Biotech Company Detail
Table 82. Janssen Biotech Business Overview
Table 83. Janssen Biotech Targeted Therapy for Breast Cancer Product
Table 84. Janssen Biotech Revenue in Targeted Therapy for Breast Cancer Business (2018-2024) & (US$ Million)
Table 85. Janssen Biotech Recent Development
Table 86. Bristol-Myers Squibb Company Detail
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Targeted Therapy for Breast Cancer Product
Table 89. Bristol-Myers Squibb Revenue in Targeted Therapy for Breast Cancer Business (2018-2024) & (US$ Million)
Table 90. Bristol-Myers Squibb Recent Development
Table 91. Gilead Sciences Company Detail
Table 92. Gilead Sciences Business Overview
Table 93. Gilead Sciences Targeted Therapy for Breast Cancer Product
Table 94. Gilead Sciences Revenue in Targeted Therapy for Breast Cancer Business (2018-2024) & (US$ Million)
Table 95. Gilead Sciences Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted Therapy for Breast Cancer Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Targeted Therapy for Breast Cancer Market Share by Type: 2022 VS 2029
Figure 3. Brand Drugs Features
Figure 4. Generic Drug Features
Figure 5. Global Targeted Therapy for Breast Cancer Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Targeted Therapy for Breast Cancer Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Other Case Studies
Figure 10. Targeted Therapy for Breast Cancer Report Years Considered
Figure 11. Global Targeted Therapy for Breast Cancer Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Targeted Therapy for Breast Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Targeted Therapy for Breast Cancer Market Share by Region: 2022 VS 2029
Figure 14. Global Targeted Therapy for Breast Cancer Market Share by Players in 2022
Figure 15. Global Top Targeted Therapy for Breast Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Therapy for Breast Cancer as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Targeted Therapy for Breast Cancer Revenue in 2022
Figure 17. North America Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Targeted Therapy for Breast Cancer Market Share by Country (2018-2029)
Figure 19. United States Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Targeted Therapy for Breast Cancer Market Share by Country (2018-2029)
Figure 23. Germany Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Targeted Therapy for Breast Cancer Market Share by Region (2018-2029)
Figure 31. China Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Targeted Therapy for Breast Cancer Market Share by Country (2018-2029)
Figure 39. Mexico Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Targeted Therapy for Breast Cancer Market Share by Country (2018-2029)
Figure 43. Turkey Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Targeted Therapy for Breast Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Eli Lilly and Company Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2018-2024)
Figure 46. Roche Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2018-2024)
Figure 47. Merck & Co. Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2018-2024)
Figure 48. Novartis Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2018-2024)
Figure 49. Pfizer Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2018-2024)
Figure 50. Merck KGaA Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2018-2024)
Figure 51. Astellas Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2018-2024)
Figure 52. Janssen Biotech Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2018-2024)
Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2018-2024)
Figure 54. Gilead Sciences Revenue Growth Rate in Targeted Therapy for Breast Cancer Business (2018-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed